XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Nvidia has nothing to fear but a lack of fear



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Nvidia has nothing to fear but a lack of fear</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Robert Cyran

NEW YORK, Sept 4 (Reuters Breakingviews) -Almost $300 billion worth of Nvidia NVDA.O got vaporized on Tuesday. It was the third sell-off in the $2.6 trillion U.S. chipmaker’s shares this year, and like the previous two, it has little basis in industrial reality. The chances are that market volatility and changeable economic data will continue to buffet Nvidia’s stock, but the biggest risk to its valuation could come later, and come from within.

Nvidia is one of the biggest beneficiaries of the race to develop artificial intelligence, as its semiconductors and networking equipment are deployed in data centers used to train and run AI systems. Revenue is expected to double this year to around $125 billion, according to analyst estimates gathered by LSEG. The outlook there hasn’t changed. Giant customers still plan to spend billions on its chips. Meta Platforms META.O, for example, intends to roughly increase its overall capital expenditure this year by around 50%, to $40 billion.

There can still be room for disappointment. The large internet and software firms that form part of its customer base may fail to monetize their AI initiatives enough to justify their $300 billion investment. At Meta, Mark Zuckerberg’s plans for open AI may turn it into a commodity. But there too, nothing has changed.

There are newer threats: the U.S. Department of Justice has accelerated a probe into whether the company unfairly gave preferential pricing and chips to companies that exclusively use Nvidia and shun its rivals, according to Bloomberg. Rival chipmaker Intel INTC.O settled with U.S. regulators over similar issues over a decade ago. But such levies are rarely very damaging. Europe slapped a fine on Intel 15 years ago, yet that case is still ongoing.

If there’s something that should worry investors, it lurks further out – and Intel offers some foreshadowing. That former giant was once the chipmaker to beat. Its peak market capitalization in 2000 of roughly $500 billion is equivalent to nearly $1 trillion in today’s money. But Intel lost its manufacturing edge to specialized manufacturer TSMC 2330.TW and missed out on the shift to chips that power cellphones. Its U.S. settlement played a role, making it easier for upstarts like Nvidia. But that was at root a problem of complacency. Intel stuck to what it knew, longer than it should have.

That kind of risk is hard to price in to a company’s shares, which probably means most investors aren’t pricing it in at all. Andy Grove, Intel’s chief executive just prior to the company’s zenith, said that “only the paranoid survive”. Intel didn’t take him at his word, but Nvidia boss Jensen Huang still can.

Follow @rob_cyran on X

CONTEXT NEWS

Nvida’s stock fell 9.5% on Sept. 3, wiping around $380 billion off the U.S. chipmaker’s market capitalization.

The U.S. Department of Justice sent subpoenas to Nvidia and other companies to investigate whether the chipmaker violated antitrust laws, according to a Bloomberg story on Sept. 3, released after the market closed.

The DOJ is investigating whether Nvidia’s purchase of Run: ai, a software maker, will make it more difficult for customers to use other firm’s chips, and whether Nvidia gives preferential pricing and supply of chips to customers that use Nvidia technology exclusively, according to Bloomberg.


Nvidia's shares have been a wobbly rocket ride https://reut.rs/3XchBav


Editing by John Foley and Pranav Kiran

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques